Search - Université Paris Cité Access content directly

Filter your results

57 Results
Structure: Internal structure identifier : 463769
Image document

Relapsed diffuse large B-cell lymphoma present different genomic profiles between early and late relapses

Julien Broséus , Gaili Chen , Sébastien Hergalant , Gérard Ramstein , Nicolas Mounier et al.
Oncotarget, 2016, 7 (51), pp.83987-84002. ⟨10.18632/oncotarget.9793⟩
Journal articles hal-02314515v1

Salvage therapy post pomalidomide-based regimen in relapsed/refractory myeloma

Guillemette Fouquet , Lionel Karlin , Margaret Macro , Denis Caillot , Murielle Roussel et al.
Annals of Hematology, 2018, 97 (5), pp.831-837. ⟨10.1007/s00277-018-3236-6⟩
Journal articles hal-01728968v1

Aplastic anemia related to thymoma: a survey on behalf of the French reference center of aplastic anemia and a review of the literature

Nicolas Gendron , Flore Sicre de Fontbrune , Alice Guyard , Jehane Fadlallah , Sylvain Chantepie et al.
Haematologica, 2020, 105 (7), pp.e333-e336. ⟨10.3324/haematol.2019.226134⟩
Journal articles hal-02962627v1

Rituximab after Autologous Stem-Cell Transplantation in Mantle-Cell Lymphoma

Steven Le Gouill , Catherine Thieblemont , Lucie Oberic , Anne Moreau , Krimo Bouabdallah et al.
New England Journal of Medicine, 2017, 377 (13), pp.1250-1260. ⟨10.1056/NEJMoa1701769⟩
Journal articles hal-02329536v1

Evolving characteristics and outcome of secondary acute promyelocytic leukemia (APL): A prospective analysis by the French-Belgian-Swiss APL group

Thorsten Braun , Sophie Cereja , Sylvie Chevret , Emmanuel Raffoux , Marie Beaumont et al.
Cancer, 2015, 121 (14), pp.2393-2399. ⟨10.1002/cncr.29389⟩
Journal articles hal-01237097v1

The European Hematology Association Roadmap for European Hematology Research: a consensus document

Jagadeesh Bayry , A. Engert , T. de Wit , T. Green , F. de Haas et al.
Haematologica, 2016, 101 (2), pp.115-208. ⟨10.3324/haematol.2015.136739⟩
Journal articles inserm-02455473v1

Umbilical cord blood transplants facilitated by the French cord blood banks network. On behalf of the Agency of Biomedicine, Eurocord and the French society of bone marrow transplant and cell therapy (SFGM-TC)

Hanadi Rafii , Federico Garnier , Annalisa Ruggeri , Irina Ionescu , Caroline Ballot et al.
Bone Marrow Transplantation, 2021, 56 (10), pp.2497-2509. ⟨10.1038/s41409-021-01313-x⟩
Journal articles hal-03628350v1

Low serum neutralization of Omicron variants a month after AZD7442 prophylaxis initiation

Xavier de Lamballerie , Guillaume Martin-Blondel , Axelle Dupont , Jacques Izopet , France Mentré et al.
Journal of Infection, 2023, 86 (1), pp.66-117. ⟨10.1016/j.jinf.2022.10.006⟩
Journal articles hal-04027487v1

Mindful Non-judging and Experiential Avoidance Before Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) are Associated to Post-traumatic Stress Disorder (PTSD) Symptomatology 5 Months Later

Maya Corman , Marie-Thérèse Rubio , Aurélie Cabrespine , Isabelle Brindel , Jacques-Olivier Bay et al.
Mindfulness, 2022, 13 (1), pp.238-247. ⟨10.1007/s12671-021-01788-1⟩
Journal articles hal-03681444v1

Efficacy and safety of the combination of rituximab, fludarabine, and mitoxantrone for rituximab-naive, recurrent/refractory follicular non-Hodgkin lymphoma with high tumor burden: a multicenter phase 2 trial by the Groupe d'Etude des Lymphomes de l'Adulte (GELA) and Groupe Ouest Est des Leucémies et Autres Maladies du Sang (GOELAMS).

Franck Morschhauser , Nicolas Mounier , Catherine Sebban , Pauline Brice , Phillippe Solal-Celigny et al.
Cancer, 2010, 116 (18), pp.4299-308. ⟨10.1002/cncr.25280⟩
Journal articles hal-00744246v1
Image document

Mobilized Multipotent Hematopoietic Progenitors Promote Expansion and Survival of Allogeneic Tregs and Protect Against Graft Versus Host Disease

Maud d'Aveni , Anne-Béatrice Notarantonio , Viviane A Agbogan , Allan Bertrand , Guillemette Fouquet et al.
Frontiers in Immunology, 2021, 11 (607180), ⟨10.3389/fimmu.2020.607180⟩
Journal articles hal-03253594v1

Quality of life in 269 patients with poor-risk diffuse large B-cell lymphoma treated with rituximab versus observation after autologous stem cell transplant

Natacha Heutte , Corinne Haioun , Pierre Feugier , Bertrand Coiffier , Herve Tilly et al.
Leukemia & lymphoma, 2011, 52 (7), pp.1239-1248. ⟨10.3109/10428194.2011.566951⟩
Journal articles hal-02358618v1

CSM de cordon ombilical : une thérapie cellulaire pour favoriser la prise de greffe de CSH sans majorer le risque de maladie du greffon contre l’hôte

Cecile Pochon , Anne-Béatrice Notarantonio , Guillemette Fouquet , David Moulin , Naceur Charif et al.
congrès de la SFGM-TC, Nov 2018, Montpellier, France
Conference papers hal-03613798v1

Predictive factors of early progression after CAR T-cell therapy in relapsed/refractory diffuse large B-cell lymphoma

Laetitia Vercellino , Roberta Di Blasi , Salim Kanoun , Benoit Tessoulin , Cedric Rossi et al.
Blood Advances, 2020, 4 (22), pp.5607-5615. ⟨10.1182/bloodadvances.2020003001⟩
Journal articles hal-03226567v1
Image document

Impact of azacitidine before allogeneic stem-cell transplantation for myelodysplastic syndromes: a study by the Société Française de Greffe de Moelle et de Thérapie-Cellulaire and the Groupe-Francophone des Myélodysplasies.

Gandhi Damaj , Alain Duhamel , Marie Robin , Yves Beguin , Mauricette Michallet et al.
Journal of Clinical Oncology, 2012, 30 (36), pp.4533-40. ⟨10.1200/JCO.2012.44.3499⟩
Journal articles inserm-00821506v1

Diffuse large B-cell lymphomas with CDKN2A deletion have a distinct gene expression signature and a poor prognosis under R-CHOP treatment: a GELA study

Fabrice Jardin , Jean-Philippe Jais , Thierry-Jo Molina , Françoise Parmentier , Jean-Michel Picquenot et al.
Blood, 2010, 116 (7), pp.1092-1104
Journal articles ensl-00816038v1

A phase 2 study of rituximab, bendamustine, bortezomib and dexamethasone for first-line treatment of older patients with mantle cell lymphoma

Rémy Gressin , Nicolas Daguindau , Adrian Tempescul , Anne Moreau , Sylvain Carras et al.
Haematologica, 2018, 104 (1), pp.138-146. ⟨10.3324/haematol.2018.191429⟩
Journal articles hal-02265274v1

Prérequis nécessaires pour la mise en place de protocoles de recherche clinique évaluant des thérapies cellulaires et géniques par lymphocytes T dotés de récepteur chimérique à l’antigène (CAR T-cells) : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC)

Ibrahim Yakoub-Agha , Christophe Ferrand , Yves Chalandon , Caroline Ballot , Cristina Castilla Llorente et al.
Bulletin du Cancer, 2017, 104 (12), pp.S43 - S58. ⟨10.1016/j.bulcan.2017.10.017⟩
Journal articles hal-01777819v1

Impact of HLA of Winning Cord Blood Unit on Outcomes after Double Umbilical Cord Blood Transplantation in Adults with Acute Leukemia: A Retrospective Study on Behalf of Eurocord, the Cord Blood Committee Cellular Therapy and Immunobiology Working Party and the Acute Leukemia Working Party of the EBMT

Federica Giannotti , Annalisa Ruggeri , Myriam Labopin , Jan Cornelissen , Mauricette Michallet et al.
Blood, 2015, 126 (23), pp.3111. ⟨10.1182/blood.V126.23.3111.3111⟩
Journal articles hal-01290435v1
Image document

Genetic characterization of B-cell prolymphocytic leukemia: a prognostic model involving MYC and TP53

Elise Chapiro , Elodie Pramil , M'Boyba Diop , Damien Roos-Weil , Clémentine Dillard et al.
Blood, 2019, 134 (21), pp.1821-1831. ⟨10.1182/blood.2019001187⟩
Journal articles hal-02363995v1

Recommandations 2015 du France Intergroupe des Leucémies Myéloïdes Chroniques pour la gestion du risque d'événements cardiovasculaires sous nilotinib au cours de la leucémie myéloïde chronique

Delphine Rea , Shanti Ame , Aude Charbonnier , Valérie Coiteux , Pascale Cony-Makhoul et al.
Bulletin du Cancer, 2016, 103 (2), pp.180-189. ⟨10.1016/j.bulcan.2015.11.008⟩
Journal articles hal-01800007v1

Lenalidomide in combination with R-CHOP (R2-CHOP) as first-line treatment of patients with high tumour burden follicular lymphoma: a single-arm, open-label, phase 2 study

Hervé Tilly , Franck Morschhauser , Olivier Casasnovas , Thierry Jo Molina , Pierre Feugier et al.
The Lancet Haematology, 2018, 5 (9), pp.e403-e410. ⟨10.1016/S2352-3026(18)30131-5⟩
Journal articles hal-02329073v1
Image document

Éligibilité des patients aux cellules CAR-T : avis d’experts proposé par la SFGM-TC

David Beauvais , Emmanuel Bachy , André Baruchel , Jacques-Olivier Bay , Denis Caillot et al.
Bulletin du Cancer, 2021, 108 (7-8), pp.725-729. ⟨10.1016/j.bulcan.2020.10.017⟩
Journal articles inserm-03349011v1

Genetic polymorphisms in ARID5B, CEBPE, IKZF1 and CDKN2A in relation with risk of acute lymphoblastic leukaemia in adults: a Group for Research on Adult Acute Lymphoblastic Leukaemia (GRAALL) study.

Pauline Peyrouze , Soizic Guihard , Nathalie Grardel , Céline Berthon , Nicolas Pottier et al.
British Journal of Haematology, 2012, 159 (5), pp.599-602. ⟨10.1111/bjh.12063⟩
Journal articles hal-00849681v1

Ponatinib evaluation and safety in real-life chronic myelogenous leukemia patients failing more than two tyrosine kinase inhibitors: the PEARL observational study

Maël Heiblig , Delphine Rea , Marie-Lorraine Chrétien , Aude Charbonnier , Philippe Rousselot et al.
Experimental Hematology, 2018, 67, pp.41 - 48. ⟨10.1016/j.exphem.2018.08.006⟩
Journal articles hal-01927788v1
Image document

Immuno-fluorescence in situ hybridization index predicts survival in patients with diffuse large B-cell lymphoma treated with R-CHOP: a GELA study.

Christiane Copie-Bergman , Philippe Gaulard , Karen Leroy , Josette Briere , Maryse Baia et al.
Journal of Clinical Oncology, 2009, 27 (33), pp.5573-9. ⟨10.1200/JCO.2009.22.7058⟩
Journal articles inserm-00424929v1

High-dose cytarabine does not overcome the adverse prognostic value of CDKN2A and TP53 deletions in mantle cell lymphoma

Marie-Hélène Delfau-Larue , Wolfram Klapper , Françoise Berger , Fabrice Jardin , Josette Brière et al.
Blood, 2015, 126 (5), pp.604-611. ⟨10.1182/blood-2015-02-628792⟩
Journal articles hal-02331700v1

Reducing mortality in newly diagnosed standard-risk acute promyelocytic leukemia in elderly patients treated with arsenic trioxide requires major reduction of chemotherapy: a report by the French Belgian Swiss APL group (APL 2006 trial)

Ramy Rahme , Lionel Ades , Xavier Thomas , Agnes Guerci-Bresler , Arnaud Pigneux et al.
Haematologica, 2018, 103 (11), pp.E519-E521. ⟨10.3324/haematol.2018.193151⟩
Journal articles hal-03605023v1
Image document

PET-adapted treatment for newly diagnosed advanced Hodgkin lymphoma (AHL2011): a randomised, multicentre, non-inferiority, phase 3 study

Rene-Olivier Casasnovas , Reda Bouabdallah , Pauline Brice , Julien Lazarovici , Hervé Ghesquieres et al.
Lancet Oncology, 2019
Journal articles hal-01996114v1

Hematopoietic stem cell transplantation for patients with paroxysmal nocturnal hemoglobinuria previously treated with eculizumab: a retrospective study of 21 patients from SFGM-TC centers

Nicolas Vallet , Flore Sicre de Fontbrune , Michaël Loschi , Déborah Desmier , Alban Villate et al.
Haematologica, 2018, 103 (3), pp.e103 - e105. ⟨10.3324/haematol.2017.182360⟩
Journal articles hal-01777807v1